The Industry Demanding Fewer Rules While Poisoning Our Water
As of January 2026, new European limits on PFAS in drinking water came into effect under a revised directive. This did not make headlines. At best, it was a delayed acknowledgment of a problem that has silently accumulated for decades in aquifers, clothing, cosmetics, and non-stick pans. PFAS—fluorinated compounds that do not decompose in nature and have been linked to cancers, infertility, and immune system degradation—include over 10,000 identified variants. Until now, regulation has managed to restrict only a tiny fraction of them.
Meanwhile, the European chemical industry is undergoing its worst structural contraction in decades: 9% of the continent’s production capacity has closed or is in the process of closing since 2022, resulting in net losses of 30.2 million annual tons in installed capacity against just 7 million tons of new investments. Germany and the Netherlands account for 45% of these closures, with an estimated 20,000 jobs affected. The diagnosis from Cefic, the European sector lobby, is unequivocal: the warning lights, they say, no longer blink; they are permanently lit.
But there is a detail that completely reframes the issue: in 2025, the chemical industry held 93 high-level meetings with commissioners and cabinets to press for reform of REACH, the regulation that has governed chemicals in Europe since 2006. Civil society organizations and health NGOs had access to just 19 meetings during the same period. This asymmetry of 5 to 1 is not a bureaucratic anomaly. It is the political architecture that explains why the dominant response to a pollution crisis is, paradoxically, to ask for less regulation.
The 4,100 Hazardous Products That Were Not Withdrawn in Time
What happens at the regulatory level has a concrete translation on the shelves of European retailers. In 2024, more than 4,100 hazardous consumer products were found circulating in the EU market, the highest figure in 20 years. The list includes cosmetics, e-cigarette liquids, clothing, jewelry, and toys. Among the most disturbing findings: BMHCA, a fragrant chemical banned in 2022 due to its links to fertility issues and skin irritation, was found in nearly all flagged cosmetics that year.
This reveals a structural fracture in the logic of REACH: the regulation can ban substances, but its enforcement capacity—detection, withdrawal, substitution—operates at a speed that does not keep pace with the rate at which new compounds are introduced to the market. The European Environment Agency estimates that 8% of deaths in Europe are attributable to exposure to hazardous chemicals, warning that this figure likely underestimates the real harm given the limited knowledge of thousands of PFAS variants.
France attempted to go further with a specific law to prohibit PFAS-containing products where viable alternatives exist. The result was a legislative process intensely pressured by the industry—cooking utensil company Tefal was cited as a key actor in this lobbying—that ended up preserving exceptions for non-stick pans. This pattern is repetitive: regulations advance, the industry negotiates the edges, and consumers bear the residual exposure that remains in the gaps.
Why "Simplifying" REACH Is the Wrong Answer to the Right Problem
The industry’s argument has an economic logic that should not be ignored. The loss of cheap Russian gas since 2022 and competition from Chinese exports priced below European costs have placed continental petrochemicals in an unsustainable financial position. Plant closures in Germany, the Netherlands, the UK, and France are driven by real margin pressures, not solely by regulatory burdens. Cefic is correct that the sector faces a risk of productive hollowing out, with geopolitical and employment consequences that cannot be overlooked.
The issue is that the proposed solution—deregulating REACH under the banner of "simplification"—does not address any of the structural causes of the competitive crisis, and risks exacerbating the health crisis. Reducing the bureaucratic burden of substance registration does not bring back natural gas, does not compress logistics costs, and does not close the wage gap with Asian manufacturing. What it would do is reopen the door to compounds with documented toxicity, generating remediation liabilities that historical experience shows end up being massively more costly than prevention. Contaminated aquifers from decades of PFAS production already represent long-term financial commitments for multiple member states.
An opinion article published in Chemical & Engineering News in April 2026 precisely points to the alternative path: investing in non-toxic materials manufactured and recycled within Europe. That proposal is not ideological; it is a competitive thesis. If Europe can position itself as the global supplier of verifiably clean industrial inputs—traceable, without PFAS, with closed recycling chains—it builds a differentiation that no cheap Chinese manufacturing can replicate in the short term. Environment Commissioner Jessika Roswall has mentioned competitive circular economy as a strategic goal, although without yet translating it into concrete industrial policy architecture.
The second Von der Leyen Commission came to power in 2024 with the pending promise to revise REACH under the auspices of the Green Deal. By mid-2025, there was no formal proposal on the table. The industry-driven "Antwerp Declaration," which prioritizes industrial competitiveness over environmental safeguards, remains the most articulated reference document in the conversation with Brussels.
The Cost of Confusing Simplification with Solution
There is a financial mechanism that the regulatory debate tends to obscure: the deferred cost of chemical pollution does not disappear with deregulation; it is transferred. It is transferred to public health systems, to water management budgets, to long-term litigation, and ultimately, to taxpayers. The recently enacted PFAS restrictions in drinking water force member states to close contaminated wells or install additional treatment infrastructure. That expense was not on the balance sheet of any chemical company; it was deferred into the collective future.
The democratization of clean chemistry—making accessible safe materials not only to large corporations but to the entire supplier chain, including SMEs—requires public investment in R&D, agile certification frameworks, and public demand that anchors initial markets. None of these levers are activated by simplifying the registration of toxic substances. Advanced materials technology, molecular traceability systems, and assisted molecular design platforms already allow for the accelerated development of PFAS-free alternatives at a decreasing marginal cost. This is the ground where Europe can build its position, not in the race to the bottom of who pollutes cheaper.
The European chemical crisis is in a state of active disruption: the inherited production model is losing financial viability, yet the sector’s response advocating deregulation preserves toxic assets instead of replacing them. Technological monitoring systems—from real-time molecular detection to supply chain traceability—already exist and are becoming cheaper. Smart regulation that integrates them as compliance tools, rather than administrative burdens, is what converts regulatory pressure into competitive advantage for those who adapt first.
